Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University of Pittsburgh |
---|---|
Information provided by: | University of Pittsburgh |
ClinicalTrials.gov Identifier: | NCT00633334 |
Therapies involving the immune system have already shown great promise in early clinical trials for the treatment of renal cell carcinoma and melanoma. One of the great challenges now facing this field is to extend these findings to other cancers. Little is currently understood about the nature of the immune response to more common gastrointestinal cancers. The first goal of this proposal is to collect blood and tissue samples from patients with early or late stage gastrointestinal cancers. These samples will be evaluated to better understand the immune response to these two cancers. The second goal of this proposal is to evaluate the specimens of these patients for changes and genetic markers that correlate with the presence of cancer. The information gathered from these studies will directly enhance our ability to design, conduct and monitor novel immunotherapeutic protocols for the treatment of patients with gastrointestinal cancer.
Condition | Intervention |
---|---|
GI Cancer |
Other: Specimen bank |
Study Type: | Observational |
Study Design: | Cohort, Cross-Sectional |
Official Title: | Investigation of the Immune Response to Gastrointestinal Tumors and Development of Novel Biomarkers for the Presence of Gastrointestinal Cancer |
peripheral blood portions of tumor tumor draining lymph nodes
Estimated Enrollment: | 1500 |
Study Start Date: | September 2003 |
Estimated Primary Completion Date: | September 2013 (Final data collection date for primary outcome measure) |
The first goal of this proposal is to collect cells from the peripheral blood, tumor draining lymph nodes and tumor infiltrating lymphocytes in patients with early or late stage gastrointestinal cancers. These samples will be evaluated in a variety of immunological assays to better understand the immune response to these two cancers.
The second goal of this proposal is to evaluate using novel proteomic, cellomic, and genomic techniques the serum and peripheral blood lymphocytes of these patients for protein, cellular changes and genetic markers that correlate with the presence of cancer. The information gathered from these studies will directly enhance our ability to design, conduct and monitor novel immunotherapeutic protocols for the treatment of patients with gastrointestinal cancer.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Potential research subjects are first identified by their primary doctor/clinical team. The research project will be discussed and mutually agreed upon between the subject and his/her caregiver before the research team will contact the subject. Other subjects are referred in specifically for possible participation in a particular study which they or their physician are aware of based on publications which list clinical trials at UPMCHS.
Inclusion Criteria:
Contact: Herbert J. Zeh, MD | 412-692-2852 | zehh@upmc.edu |
Contact: Amy R Schmotzer, RN, BSN | (412) 647-6205 | schmotzerar@upmc.edu |
United States, Pennsylvania | |
University of Pittsburgh Cancer Institute | Recruiting |
Pittsburgh, Pennsylvania, United States, 15232 | |
Contact: Herbert J. Zeh, MD 412-692-2852 zehh@upmc.edu |
Principal Investigator: | Herber J. Zeh, MD | University of Pittsburgh |
Responsible Party: | University of Pittsburgh Medical Center ( Herbert J. Zeh, III, MD ) |
Study ID Numbers: | 02-077 |
Study First Received: | March 3, 2008 |
Last Updated: | June 18, 2009 |
ClinicalTrials.gov Identifier: | NCT00633334 History of Changes |
Health Authority: | United States: Institutional Review Board |
Cancer GI Tumor Gastrointestinal high risk |
Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms |
Neoplasms Digestive System Diseases Neoplasms by Site |
Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms |